# Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects

> **NCT04904601** · NA · COMPLETED · sponsor: **Chair for Biomarkers of Chronic Diseases** · enrollment: 100 (actual)

## Conditions studied

- Obesity
- Metabolic Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Kale supplement
- **DIETARY_SUPPLEMENT:** Peas supplement

## Key facts

- **NCT ID:** NCT04904601
- **Lead sponsor:** Chair for Biomarkers of Chronic Diseases
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-15
- **Primary completion:** 2022-09-28
- **Final completion:** 2022-09-28
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904601, "Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04904601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*